ETFs Attract $6B. Investors Buy $3.7B Of Fixed Income ETFs

On net, nearly $6 billion flowed into U.S.-listed ETFs during the week ending Thursday, Sep. 5, according to FactSet. That puts year-to-date inflows at $150.7 billion, less than the $176.1 billion at this same time last year. U.S. Fixed Income ETFs picked up $3.7 billion. Bank of America Merrill Lynch is bullish on risk assets for 2019. Read Full Strategy:

mRNA: Profit From A New Frontier Of Disease Treatment

Using mRNA as a medicine is a fundamentally different approach than treating disease with other drug classes. What is mRNA? mRNA is the set of instructions by which cells make all proteins and send them to various parts of the body. Why mRNA? mRNA medicines take advantage of normal biological processes to express proteins and create a desired therapeutic effect. This enables the potential treatment of a broad spectrum of diseases, many of which cannot be addressed with current technologies. Read Full Strategy: